Karin Hehenberger

President at Lyfebulb, Chief Medical Officer, Patient Care America, Health care executive, Patient leader, Independent board member

Karin Hehenberger is a prominent figure in the life sciences sector, currently serving as the President of Lyfebulb and the Chief Medical Officer at Patient Care America. With nearly 25 years of experience, she has held significant roles in various organizations, including Eyetech Pharmaceuticals and Coronado BioSciences, and has had strategic positions at Johnson & Johnson and JDRF (Juvenile Diabetes Research Foundation) .1 2 3

Education and Early Career

Dr. Hehenberger earned her MD and PhD from the Karolinska Institute and completed a post-doctoral fellowship at the Joslin Diabetes Center, affiliated with Harvard Medical School. Her early career included senior roles in management consulting at McKinsey and partnership positions in investment funds focused on life sciences .1 2

Contributions to Patient Care

At Lyfebulb, she focuses on empowering patients with chronic diseases through innovative solutions. Her leadership aims to enhance patient engagement and improve health outcomes .1 3 Additionally, her work at Patient Care America emphasizes personalized care strategies, particularly for individuals with diabetes .1 2

Personal Insights

Dr. Hehenberger's personal experiences with type 1 diabetes have profoundly influenced her professional journey, driving her commitment to patient advocacy and empowerment in healthcare .1 4